HIV Viral Suppression With Long-Acting Antiretroviral Therapy

This study uses electronic medical record data to compare 48-week viral load outcomes after starting long-acting antiretroviral therapy among people in the US with HIV with or without viremia from January 2021 through September 2024. Source link

Unintentional Fentanyl Use Detected in Hair

This study assessed hair samples to detect fentanyl exposure among people with or at risk of HIV reporting methamphetamine use without intention to use opioids concomitantly. Source link

Advances in Treatment and Prevention of HIV

Advances in antiretroviral therapy (ART) has led to HIV being a manageable and preventable condition and provides the tools that might lead to an end of the HIV pandemic. Despite these advances, in the United States there were approximately 30 000 new infections in 2022, less than 70% of people living with HIV were virologically suppressed, […]

Elective Surgery for People With HIV With Low CD4 Count

This case report describes a man in his 60s with hypertension, deep vein thrombosis, and a recent diagnosis of HIV presented with low CD4 cell count after starting antiretroviral therapy with tenofovir alafenamide-emtricitabine-bictegravir. Source link

DoxyPEP Shows Promise for Reducing STIs in 2 Studies

Amid the ongoing threat of sexually transmitted infections (STIs), doxycycline postexposure prophylaxis (doxyPEP)—a preventive treatment in which individuals take a dose of doxycycline up to 3 days after unprotected sex—could help reduce cases, according to 2 studies published in JAMA Internal Medicine. Source link